Commodore Capital as of March 31, 2023
Portfolio Holdings for Commodore Capital
Commodore Capital holds 32 positions in its portfolio as reported in the March 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Xenon Pharmaceuticals (XENE) | 10.1 | $66M | 1.8M | 35.79 | |
Miragen Therapeutics (VRDN) | 8.5 | $56M | 2.2M | 25.44 | |
Merus N V (MRUS) | 8.3 | $54M | 3.0M | 18.40 | |
Cogent Biosciences (COGT) | 7.8 | $52M | 4.8M | 10.79 | |
Bellus Health Com New | 7.2 | $47M | 6.6M | 7.20 | |
Ambrx Biopharma Sponsored Ads | 6.5 | $43M | 4.8M | 8.92 | |
Enliven Therapeutics (ELVN) | 5.8 | $38M | 1.7M | 21.90 | |
Akero Therapeutics (AKRO) | 4.6 | $30M | 790k | 38.26 | |
Nuvalent Inc-a (NUVL) | 4.3 | $28M | 1.1M | 26.09 | |
Immunovant (IMVT) | 3.4 | $22M | 1.4M | 15.51 | |
Vera Therapeutics Cl A (VERA) | 3.3 | $22M | 2.8M | 7.76 | |
Syndax Pharmaceuticals (SNDX) | 2.7 | $18M | 854k | 21.12 | |
Celldex Therapeutics Com New (CLDX) | 2.7 | $18M | 496k | 35.98 | |
Cymabay Therapeutics | 2.7 | $18M | 2.0M | 8.72 | |
Cabaletta Bio (CABA) | 2.3 | $15M | 1.8M | 8.27 | |
Kura Oncology (KURA) | 2.2 | $15M | 1.2M | 12.23 | |
Arrowhead Pharmaceuticals (ARWR) | 2.2 | $15M | 575k | 25.40 | |
Celcuity (CELC) | 2.2 | $14M | 1.4M | 10.25 | |
Prometheus Biosciences | 2.1 | $14M | 127k | 107.32 | |
Alpine Immune Sciences | 1.6 | $10M | 1.3M | 7.72 | |
Day One Biopharmaceuticals I (DAWN) | 1.5 | $9.9M | 740k | 13.37 | |
Avidity Biosciences Ord (RNA) | 1.4 | $9.1M | 591k | 15.35 | |
Enanta Pharmaceuticals (ENTA) | 1.3 | $8.8M | 217k | 40.44 | |
Allakos (ALLK) | 1.3 | $8.5M | 1.9M | 4.45 | |
Vaxcyte (PCVX) | 1.1 | $7.5M | 200k | 37.48 | |
Aclaris Therapeutics (ACRS) | 0.8 | $5.1M | 635k | 8.09 | |
Third Harmonic Bio (THRD) | 0.6 | $4.1M | 993k | 4.12 | |
Adverum Biotechnologies | 0.5 | $3.6M | 5.0M | 0.72 | |
Kalvista Pharmaceuticals (KALV) | 0.4 | $2.5M | 313k | 7.86 | |
Rezolute Com New (RZLT) | 0.3 | $1.7M | 898k | 1.92 | |
Acumen Pharmaceuticals (ABOS) | 0.2 | $1.6M | 400k | 4.06 | |
Dbv Technologies S A Sponsored Adr | 0.0 | $157k | 93k | 1.69 |